English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/58806
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorRamos, Irene-
dc.contributor.authorAlonso, Ana-
dc.contributor.authorMarcen, Jose Miguel-
dc.contributor.authorPeris, Ana-
dc.contributor.authorCastillo Hernández, Juan Antonio-
dc.contributor.authorColmenares, María-
dc.contributor.authorLarraga, Vicente-
dc.date.issued2008-01-17-
dc.identifier.citationVaccine 26(3):333-44(2008)es_ES
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10261/58806-
dc.description12 páginas, 5 figuras, 1 tabla -- PAGS nros. 333-344es_ES
dc.description.abstractLeishmaniasis caused by Leishmania infantum is a severe endemic disease in the Mediterranean basin, being domestic dogs the main reservoir of the disease that plays a key role in the transmission to humans. Studies on vaccines against canine leishmaniasis, aimed to modify the T cell repertoire, have advanced in recent years. LACK vaccination assays, using protein or DNA vectors, show protection against cutaneous L. major infections by redirecting the early IL-4 responses to a protective Th1 response. The aim of this study was to define the effectiveness and type of immune response in a canine visceral leishmaniasis model of two poxvirus vectors (Western reserve strain, WR and modified vaccinia virus Ankara, MVA) expressing the LACK protein of L. infantum in prime/boost vaccination protocols. The results obtained showed that dog vaccination priming with DNA-LACK followed by a booster with MVA-LACK or rVV-LACK triggered a Th1 type of immune response, leading to protection against canine visceral leishmaniasis. This protection correlated with absence of visceral leishmaniasis symptoms, lower Leishmania-specific antibodies, higher degree of T cell activation in Leishmania-target organs and higher synthesis of Th1 cytokines. In addition, we found that dogs boosted with the non-replicative virus show less VL symptoms and higher degree of T cell activation, providing evidences for a clear advantage of MVA-LACK as a vaccination vector against canine visceral leishmaniasises_ES
dc.description.sponsorshipThis work has been partially financed by grant AGL2003-06152-C02-01/02 of the Spanish Ministry of Education and Science. I. Ramos is a recipient of a predoctoral fellowship from the Spanish Ministry of Education and Sciencees_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsclosedAccesses_ES
dc.subjectLeishmania infantumes_ES
dc.subjectCanine visceral leishmaniasises_ES
dc.subjectLACKes_ES
dc.subjectDNA vaccinees_ES
dc.subjectImmune responsees_ES
dc.subjectModified vaccinia virus Ankaraes_ES
dc.titleHeterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune responsees_ES
dc.typeartículoes_ES
dc.identifier.doi10.1016/j.vaccine.2007.11.021-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.vaccine.2007.11.021es_ES
dc.identifier.e-issn1873-2518-
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.